Priapism and multiple myeloma. Successful treatment with plasmapheresis

Urology
|August 1, 1978
PubMed

Insights

Priapism in a sixty-year-old male was linked to multiple myeloma and hyperviscosity. Plasmapheresis resolved priapism, while chemotherapy prevented recurrence, resolving a 17-year history.

Area of Science:

  • Hematology
  • Urology

Background:

  • Multiple myeloma is a plasma cell malignancy.
  • Hyperviscosity syndrome can complicate hematological disorders.
  • Priapism is a prolonged erection, often painful and unrelated to sexual stimulation.

Observation:

  • A sixty-year-old Black male presented with priapism.
  • The patient had a concurrent diagnosis of multiple myeloma.
  • Laboratory findings indicated hyperviscosity.

Findings:

  • Plasmapheresis, a procedure to remove plasma, effectively treated the hyperviscosity.
  • Successful treatment of hyperviscosity led to the resolution of priapism.
  • Chemotherapy targeting multiple myeloma prevented the recurrence of priapism.

Implications:

  • This case highlights the association between multiple myeloma, hyperviscosity, and priapism.
  • It demonstrates the efficacy of plasmapheresis in managing priapism secondary to hyperviscosity.
  • Effective management of the underlying multiple myeloma is crucial for long-term priapism prevention.